PharmAust Limited (#ASX: $PAA) advises preliminary Positive Results for the Treatment of SARS-CoV-2 Viral Infection by Monepantel. Requires further confirmation in repeat and more comprehensive studies. https://t.co/d2jtpd5OUm. #COVID19 #clinicaltrials #stocks #biotech. https://t.co/wfxV9RfU8f